Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocCheck AG's ROE % for the quarter that ended in Dec. 2025 was 14.32%. DocCheck AG's PB Ratio for the quarter that ended in Dec. 2025 was 1.45.
DocCheck AG's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 9.88%.
DocCheck AG ROE % Adjusted to Book Value Related Terms
DocCheck AG ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for DocCheck AG's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:AJ91 vs VEEV, BTSG, TEM: ROE % Adjusted to Book Value Comparison
For the Health Information Services subindustry, DocCheck AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocCheck AG ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where DocCheck AG's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 9.88% mean?
DocCheck AG (HAM:AJ91) has a ROE % Adjusted to Book Value of 9.88% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on DocCheck AG and its competitors.
Is DocCheck AG's ROE % Adjusted to Book Value too high?
DocCheck AG's current ROE % Adjusted to Book Value is 9.88%. Overall, DocCheck AG has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's ROE % Adjusted to Book Value compare to VEEV and BTSG?
DocCheck AG's ROE % Adjusted to Book Value of 9.88% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on DocCheck AG and its competitors. DocCheck AG's current ROE % Adjusted to Book Value is 9.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
DocCheck AG (HAM:AJ91) has a current ROE % Adjusted to Book Value of 9.88%. The stock's GF Value™ is €9.52, compared to a current price of €11.90 — trading 25% above its estimated fair value. The current ROE % Adjusted to Book Value is 9.88%. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For DocCheck AG (HAM:AJ91), the current ROE % Adjusted to Book Value is 9.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocCheck AG (HAM:AJ91) Overvalued in 2026?
Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued.
The current stock price of €11.90 is trading 25% above its estimated GF Value™ of €9.52.
Key valuation signals for HAM:AJ91:
ROE % Adjusted to Book Value: 9.88%
GF Value™: €9.52 vs. price of €11.90 (25% above fair value)
No single metric tells the full story. See the HAM:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score
Get the complete analysis for HAM:AJ91
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:AJ91 has been successfully added to your 
